MicroRNA let-7a: A potential marker for selection of paclitaxel in ovarian cancer management
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference38 articles.
1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008
2. Triple cytotoxic therapy for advanced ovarian cancer: a failed application, not a failed strategy;Hoskins;J Clin Oncol,2009
3. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup;Bookman;J Clin Oncol,2009
4. Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer;Piccart;Int J Gynecol Cancer,2003
5. How microRNAs control cell division, differentiation and death;Miska;Curr Opin Genet Dev,2005
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The microRNA Let-7 and its exosomal form: Epigenetic regulators of gynecological cancers;Cell Biology and Toxicology;2024-06-05
2. Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool;Frontiers in Molecular Biosciences;2024-04-16
3. MiRNAs related in signaling pathways of women’s reproductive diseases: an overview;Molecular Biology Reports;2024-03-12
4. Detection of intracellular microRNA-21 for cancer diagnosis by a nanosystem containing a ZnO@polydopamine and DNAzyme probe;RSC Advances;2024
5. Insight on Non-Coding RNAs from Biofluids in Ovarian Tumors;Cancers;2023-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3